findmyKOL

Patricia Lorusso, DO

Enriched profile

Amy and Joseph Perella Professor of Medicine (Medical Oncology); Chief of Experimental Therapeutics; Associate Cancer Center Director, Experimental Therapeutics · Yale School of Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Detroit, MI · Midwest · United StatesSpecialtyMedical OncologyFocusLung Cancer Treatments and Mutations+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1995–2013

Patricia Lorusso is Amy and Joseph Perella Professor of Medicine (Medical Oncology); Chief of Experimental Therapeutics; Associate Cancer Center Director, Experimental Therapeutics at Yale School of Medicine. OpenAlex indexes 1,281 publications with 34,992 citations (h-index 87); ClinicalTrials.gov lists 31 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Medical Oncology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Patricia M. LoRusso, DO, is Amy and Joseph Perella Professor of Medicine (Medical Oncology) at Yale School of Medicine / Yale Cancer Center. The public record shows 1,281 publications with 34,992 citations (h-index 87), centered on Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology, Cancer Immunotherapy and Biomarkers. It also documents an investigator role on 31 registered clinical trials, industry payments reported by 22 companies, 4 NIH-funded awards (1995–2013).

  • Most recent indexed publication: 2026 · Clinical cancer research
  • Top research focus: Lung Cancer Treatments and Mutations
  • 31 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 22 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Breast Cancer7 trialsLymphoma4 trialsLung Cancer (NSCLC/SCLC)3 trialsPancreatic Cancer3 trialsMelanoma3 trialsHodgkin Disease3 trialsHepatobiliary Cancer2 trialsCholangiocarcinoma2 trialsColorectal Cancer2 trialsPrecursor Cell Lymphoblastic Leukemia-Lymphoma2 trialsLymphoma, Non-Hodgkin2 trialsLeukemia, Lymphocytic, Chronic, B-Cell2 trialsLymphoma, Follicular2 trialsBurkitt Lymphoma2 trialsLymphoma, B-Cell, Marginal Zone2 trialsLymphoma, B-Cell2 trialsWaldenstrom Macroglobulinemia2 trialsGranuloma2 trialsLymphomatoid Granulomatosis2 trialsSmall Cell Lung Carcinoma2 trialsNeuro-Oncology / Glioma1 trialGlioma1 trialRectal Neoplasms1 trialKidney Cancer / RCC1 trialColonic Neoplasms1 trialKidney Neoplasms1 trialLeukemia (AML/ALL/CML/CLL)1 trialMycosis Fungoides1 trialSezary Syndrome1 trialLymphoma, T-Cell1 trialLeukemia, T-Cell1 trialSalivary Gland Neoplasms1 trialCarcinoma, Adenoid Cystic1 trialCysts1 trialMultiple Sclerosis1 trialRheumatoid Arthritis1 trialPsoriasis / Psoriatic Arthritis1 trialLupus (SLE)1 trialIBD (Crohn's / UC)1 trialCrohn Disease1 trialColitis, Ulcerative1 trialST Elevation Myocardial Infarction1 trialAutoimmune Diseases1 trialScleroderma, Systemic1 trialSjogren's Syndrome1 trialUlcer1 trialMyositis1 trialDermatomyositis1 trialColitis1 trialErythema1 trialHead & Neck Cancer1 trialEndometrial Neoplasms1 trial

Research focus

OpenAlex concept fingerprint
Lung Cancer Treatments and MutationsCancer Treatment and PharmacologyCancer Immunotherapy and BiomarkersPARP inhibition in cancer therapyHER2/EGFR in Cancer Research

Drugs & molecules

across trials, industry payments and publications
Lumakrasgeneric · SotorasibClinical trials—Industry payments3Publications—Elzonrisgeneric · TagraxofuspClinical trials—Industry payments2Publications—GV20-0251Clinical trials1Industry payments—Publications—GV20-0251 and Pembrolizumab [KEYTRUDA®]Clinical trials1Industry payments—Publications—Imfinzigeneric · DurvalumabClinical trials—Industry payments1Publications—Tukysageneric · TucatinibClinical trials—Industry payments1Publications—Xcoprigeneric · CenobamateClinical trials—Industry payments1Publications—Zepzelcageneric · LurbinectedinClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Boehringer Ingelheim International GmbHClinical trials—Industry payments54Amgen Inc.Clinical trials—Industry payments18Boehringer Ingelheim Pharma GmbH & Co.KGClinical trials—Industry payments15National Cancer Institute (NCI)Clinical trials14Industry payments—Merck Sharp & Dohme LLCClinical trials—Industry payments13AstraZeneca Pharmaceuticals LPClinical trials—Industry payments7Pfizer Inc.Clinical trials—Industry payments7Barbara Ann Karmanos Cancer InstituteClinical trials6Industry payments—Merck Healthcare KGaAClinical trials—Industry payments5Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments4F. Hoffmann-La Roche AGClinical trials—Industry payments4GlaxoSmithKline, LLC.Clinical trials—Industry payments4AstraZeneca UK LimitedClinical trials—Industry payments3Kyowa Kirin, Inc.Clinical trials—Industry payments3AstraZenecaClinical trials2Industry payments—EMD Serono Research & Development Institute, Inc.Clinical trials—Industry payments2Genentech USA, Inc.Clinical trials—Industry payments2Genentech, Inc.Clinical trials—Industry payments2Seagen Inc.Clinical trials—Industry payments2Stemline Therapeutics Inc.Clinical trials—Industry payments2CelgeneClinical trials1Industry payments—Eli Lilly and CompanyClinical trials—Industry payments1Foundation Medicine, Inc.Clinical trials—Industry payments1Gilead SciencesClinical trials1Industry payments—Gilead Sciences, Inc.Clinical trials—Industry payments1GV20 TherapeuticsClinical trials1Industry payments—Incendia TherapeuticsClinical trials1Industry payments—INSYS Therapeutics IncClinical trials1Industry payments—Jazz Pharmaceuticals Inc.Clinical trials—Industry payments1SK Life Science, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,281publications

Distinct works indexed by OpenAlex, matched via ORCID; 25 in PubMed.

34,992citations

Total citations across indexed works.

87h-index

Hirsch index (OpenAlex). i10-index 389.

Clinical & industry

trials, payments and federal funding
31clinical trials

Investigator role on registered studies.

View trials ↓
22companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
4NIH grants · 1995–2013

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 31 registered studies on ClinicalTrials.gov. The most recent:

All 31 trial records: search, sort and filter.Explore →

Industry payments

Updated 14 Oct 2026

22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 38 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

Updated 14 Oct 2026

4 NIH research awards on record, funded 1995–2013 per NIH RePORTER. The latest:

All 45 award records: search, sort and filter.Explore →

Congress activity

Updated 14 Oct 2026

272 congress contributions (2004–2026) across AACR, ASCO, ASH, ESMO, SABCS per OpenAlex. The most recent:

All 272 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 25 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
    Article1,281 citations2012
    doi.org ↗
  2. 02
    Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
    Article1,123 citations2012
    doi.org ↗
  3. 03
    Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
    Article1,112 citations2009
    doi.org ↗
  4. 04
    Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
    Article1,015 citations2009
    doi.org ↗
  5. 05
    Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer
    Article841 citations2015
    doi.org ↗
All 1,281 cited works: search, sort and filter.Explore →

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Geoffrey I. Shapiro130Scott A. Boerner123Anthony W. Tolcher112Howard A. Burris110Kyriakos P. Papadopoulos102Joseph P. Eder102Manish R. Patel77Mary Jo Pilat75Pamela N. Münster72Todd M. Bauer68Michael Cecchini66Kurt A. Schalper62Mrinal M. Gounder61Monica Mita60Elisabeth I. Heath58Timothy A. Yap56Alice P. Chen55Wei Wei54Gerald S. Falchook53Amita Patnaik51Lance K. Heilbrun49Josep Tabernero49Razelle Kurzrock48Daniel D. Von Hoff48Johanna C. Bendell47Noboru Yamamoto46Scott A. Laurie46Shivaani Kummar45David S. Hong45Diane E. Durecki45Navid Hafez43Jordi Rodón43Michael Teufel43Jeffrey R. Infante43Mehdi Lahmar42Junxian Geng42Teffany Davenport41Alain C. Mita39Ron H.J. Mathijssen39Jean‐Charles Soria38

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • ResearchGate

    researchgate.net/profile/Patricia-Lorusso

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Instagram

    instagram.com/aacr_foundation/p/C-8BOdbpjDX

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MA

    Yale University

    2015
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Honorary PhD (hc)

    Michigan State University

    2015
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.yale.edu ↗
  • Board Certified

    Medical Oncology, American Osteopathic Board

    1991
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Fellowship

    Wayne State University

    1988
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.yale.edu ↗
  • Board Certified

    Internal Medicine, American Osteopathic Board

    1987
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Residency

    Riverside Osteopathic Hospital

    1982
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.yale.edu ↗
  • DO

    Michigan State University

    1981
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • BS

    Marygrove College

    1977
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗

Editorial & leadership roles

journal and society appointments
  • Scientific Advisory Board member

    Akari Therapeutics

    2026
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biospace.com ↗
  • President

    American Association for Cancer Research (AACR), 2024-2025

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aacr.org ↗
  • Former Co-Chair

    NCI Cancer Therapy Evaluation Program (CTEP) Investigational Drug Steering Committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Current editorial board member

    Clinical Cancer Research

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Former editor

    Investigational New Drugs

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.